Skip to main content
 

Our Abilify News

Below are some of our news stories explaining the potential dangers of Abilify, and especially the connection to compulsive behavior, such as gambling, shopping, eating and sex. To learn more about the types of injuries that have been linked to this medication, and the legal claims that have been filed, click Abilify.

 

In a recent decision by a Florida federal judge, Abilify maker Otsuka Pharmaceuticals was absolved of responsibility to preserve company e-mails that might have served as evidence for plaintiffs…

Japan-based Otsuka Pharmaceuticals and its US partner, Bristol-Meyer Squibb, have settled three Abilify lawsuits that were scheduled to go to trial this summer. The plaintiffs, who suffer from…

Despite demonstrated dangers and side effects, which are the primary cause of action in the dozens of lawsuits currently part of a mass tort action, the atypical antipsychotic medication Abilify…

If “three strikes” laws applied to corporate “people” as they do to natural humans, Bristol-Myers Squibb (BMS) would be spending the rest of its life behind bars. Unfortunately, as we have seen,…

Award winning personal injury attorney Troy Rafferty, a shareholder with the Levin Papantonio Law Firm, has been appointed to the leadership team handling cases related to the Abilify (…

In May of 2016, the FDA finally issued a warning about the antidepressant medication aripiprizole, sold under the brand name Abilify as well as in generic form. That warning stated that use of…

The latest drug with harmful side effects now being targeted in litigation is an anti-psychotic medication known as aripiprazole, sold under the brand name Abilify as well as in generic…

Subscribe to Abilify News
Customize This